All In MedTech

Device Trial Radar · NCT07630064

Flo Digital Contraceptive Study

Flo Digital Contraceptive Study: Safety and Effectiveness of Flo's Personalized Fertility Awareness Tool for Preventing Pregnancy

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

3,800

Planned (sponsor's estimate)

Start

Apr 22, 2026

Primary completion

Jan 10, 2028

Study completion Jan 10, 2028

Sponsor

Lead sponsor
Flo Health Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Exponent
First posted
Jun 5, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if the Flo Digital Contraceptive (FDC) app can effectively prevent unintended pregnancy in women aged 18 years and older residing in the United States. The main questions it aims to answer are: 1. What is the rate of unintended pregnancy in women aged 18-35 years using FDC as their sole method of contraception under typical-use conditions, measured using the Pearl Index? 2. What is the cumulative probability of unintended pregnancy over 13 menstrual cycles for all participants, including those with regular and irregular cycles? Participants will: * Use the Flo Digital Contraceptive app in 'prevent pregnancy' mode as their primary method of contraception for up to 13 menstrual cycles or 18 months, whichever comes first * Wear an Apple Watch (Series 8 or later, or Ultra or SE3) while sleeping to collect nightly wrist temperature data, which the app uses to detect ovulation * Log menstrual cycles, sexual activity, and any use of emergency contraception directly in the Flo app * Complete monthly electronic surveys (ePROs) administered by the study team covering pregnancy status, adherence, safety, and experience * Complete a baseline demographic survey at enrollment and an exit survey at the end of participation

Conditions

  • Contraception Use

Interventions

  • Flo Digital ContraceptiveDevice

    The Flo Digital Contraceptive (FDC) is a fertility awareness-based Software as a Medical Device (SaMD) integrated within the Flo Period \& Cycles Tracker app (iOS) in 'prevent pregnancy' mode. The FDC uses a proprietary machine-learning algorithm to classify each day of the user's menstrual cycle as either 'Not fertile' (unprotected intercourse permitted) or 'Use protection' (abstinence or barrier contraception required). Classifications are generated dynamically using menstrual cycle history and overnight wrist-skin temperature measured via Apple Watch (Series 8 or later, or Ultra), synchronized daily through Apple Health, with optional urinary LH test results as a supplementary input. Participants use FDC as their sole method of contraception for up to 13 menstrual cycles or 18 months from device activation, whichever occurs first.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Typical-Use Pearl Index in Women Aged 18-35 Years with Regular Menstrual CyclesTime frame: Up to 13 menstrual cycles or 18 months from FDC activation, whichever occurs first.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Exponent

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.